Axxcess Wealth Management LLC Grows Stock Position in Procter & Gamble Company (The) $PG

Axxcess Wealth Management LLC increased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 0.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 90,641 shares of the company’s stock after buying an additional 254 shares during the period. Axxcess Wealth Management LLC’s holdings in Procter & Gamble were worth $14,441,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MOKAN Wealth Management Inc. increased its stake in shares of Procter & Gamble by 13.7% during the 2nd quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock valued at $2,442,000 after acquiring an additional 1,846 shares during the last quarter. Benjamin Edwards Inc. raised its stake in Procter & Gamble by 120.7% during the first quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock valued at $62,098,000 after buying an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC lifted its holdings in Procter & Gamble by 13.8% during the 1st quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company’s stock worth $6,426,000 after buying an additional 4,562 shares during the last quarter. World Investment Advisors lifted its holdings in Procter & Gamble by 6.0% during the 1st quarter. World Investment Advisors now owns 50,913 shares of the company’s stock worth $8,677,000 after buying an additional 2,886 shares during the last quarter. Finally, Concurrent Investment Advisors LLC lifted its holdings in Procter & Gamble by 26.4% during the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company’s stock worth $20,451,000 after buying an additional 25,059 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CEO Jennifer L. Davis sold 3,227 shares of the firm’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the transaction, the chief executive officer directly owned 61,764 shares of the company’s stock, valued at $9,402,333.72. This trade represents a 4.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the transaction, the chief operating officer directly owned 46,899 shares of the company’s stock, valued at approximately $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 149,763 shares of company stock valued at $23,421,279 in the last ninety days. Company insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on PG. Berenberg Bank raised their price objective on Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday. BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a research note on Tuesday, September 23rd. Bank of America reduced their price objective on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Finally, UBS Group reduced their price objective on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research note on Wednesday, October 8th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $172.21.

Procter & Gamble Price Performance

NYSE:PG opened at $147.54 on Tuesday. Procter & Gamble Company has a 52-week low of $146.96 and a 52-week high of $180.43. The business’s 50-day moving average price is $155.18 and its 200 day moving average price is $159.27. The firm has a market cap of $345.32 billion, a P/E ratio of 22.66, a PEG ratio of 3.97 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the company earned $1.40 EPS. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, sell-side analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.